Holen Sie sich die Stockscreener-App
7.17
2.87%
0.20
Handel nachbörslich:
7.03
-0.14
-1.95%
Alpha Tau Medical Ltd Aktie (DRTS) Neueste Nachrichten
Citigroup Forecasts Strong Price Appreciation for Alpha Tau Medical (NASDAQ:DRTS) Stock - Defense World
HC Wainwright Has Negative Estimate for DRTS Q1 Earnings - Defense World
Short Squeeze: Will Alpha Tau Medical Ltd benefit from rate cuts2026 Fundamental Recap & Low Drawdown Momentum Ideas - baoquankhu1.vn
HC Wainwright Issues Pessimistic Estimate for DRTS Earnings - MarketBeat
Citigroup Increases Alpha Tau Medical (NASDAQ:DRTS) Price Target to $9.00 - MarketBeat
Alpha Tau Medical (NASDAQ:DRTS) Given Buy Rating at HC Wainwright - Defense World
Piper Sandler cuts Alpha Tau Medical stock rating on valuation - Investing.com Nigeria
HC Wainwright Reaffirms "Buy" Rating for Alpha Tau Medical (NASDAQ:DRTS) - MarketBeat
Alpha Tau Medical: U.S. Trial Expansion, Japan Approval, and Manufacturing Scale-Up Support Buy Rating Despite Near-Term Losses - TipRanks
Alpha Tau Medical (NASDAQ:DRTS) Issues Earnings Results, Misses Estimates By $0.01 EPS - MarketBeat
Alpha Tau Posts Wider 2025 Loss as Japanese Approval and U.S. Trial Progress Mark Pivotal Year - TipRanks
Alpha Tau Announces Full Year 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Trade Report: Is Alpha Tau Medical Ltd Equity Warrant stock a good pick for beginners2026 Volatility Report & AI Enhanced Trading Alerts - baoquankhu1.vn
Is Alpha Tau Medical Ltd. Equity Warrant benefiting from interest rate changesPortfolio Value Summary & Growth-Oriented Investment Plans - mfd.ru
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Receives $7.00 Average PT from Analysts - Defense World
Piper Sandler Reaffirms Neutral Rating for Alpha Tau Medical (NASDAQ:DRTS) - Defense World
Alpha Tau Medical Shares Fall After Piper Sandler Downgrade - marketscreener.com
DRTS Receives Downgrade from Piper Sandler with Neutral Rating | - GuruFocus
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Piper Sandler Reiterates Neutral Rating for Alpha Tau Medical (NASDAQ:DRTS) - MarketBeat
Piper Sandler cuts Alpha Tau Medical stock rating on valuation By Investing.com - Investing.com Canada
Alpha Tau Medical (DRTS) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
DRTS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Alpha Tau Medical Ltd. (DRTS) Stock Analysis: Exploring a 6.89% Upside in Innovative Cancer Treatment Technology - DirectorsTalk Interviews
Alpha Tau Medical (DRTSW) to Release Earnings on Thursday - Defense World
DRTS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Alpha Tau Medical (NASDAQ:DRTS) Sets New 1-Year HighWhat's Next? - MarketBeat
H.C. Wainwright raises Alpha Tau Medical price target on Japan approval - Investing.com Nigeria
Shorts Report: Will Alpha Tau Medical Ltd benefit from rate cutsJuly 2025 Rallies & Daily Momentum Trading Reports - baoquankhu1.vn
Alpha Tau price target raised to $12 from $9 at H.C. Wainwright - Yahoo Finance
Alpha Tau Lands First International Approval as Japan Grants Mar - GuruFocus
Alpha Tau Lands First International Approval as Japan Grants Marketing Clearance for Alpha DaRT (NASDAQ: DRTS) - TipRanks
H.C. Wainwright Maintained Buy on Alpha Tau Medical Ltd. (DRTS) Feb 2026 - Meyka
HekaBio and Alpha Tau Medical Obtain Approval in Japan for Solid Tumor Treatment Alpha DaRT - BioSpace
Alpha Tau Medical Says Its Head and Neck Cancer Medication Received Japanese Marketing Approval - marketscreener.com
Alpha Tau Wins First Overseas Approval as Japan Clears Alpha DaRT Cancer Therapy - TipRanks
Alpha Tau Medical receives Japanese marketing approval for Alpha Dart in head and neck cancer - marketscreener.com
Japan grants Shonin approval for Alpha Tau (DRTS) Alpha DaRT cancer therapy - Stock Titan
Alpha Tau Medical Receives Japanese Marketing Approval for - GlobeNewswire
Alpha Tau Medical (DRTSW) Stock Analysis Report | Financials & Insights - Benzinga España
CEO Change: Will MPLX benefit from seasonalityPortfolio Gains Summary & Consistent Growth Equity Picks - baoquankhu1.vn
Risk Off: What is FORLUs valuation compared to sectorPortfolio Value Summary & Risk Controlled Stock Alerts - baoquankhu1.vn
Retail Trends: Will Alpha Tau Medical Ltd Equity Warrant benefit from rising consumer demand2025 Price Momentum & Fast Gain Stock Tips - baoquankhu1.vn
Macro Review: Will Plumas Bancorp benefit from rising consumer demandJuly 2025 Outlook & Reliable Price Action Trade Plans - baoquankhu1.vn
Aug PreEarnings: Can Alpha Tau Medical Ltd sustain its profitabilityJuly 2025 Big Picture & AI Forecasted Stock Moves - baoquankhu1.vn
Lucid Diagnostics (NASDAQ:LUCD) & Alpha Tau Medical (NASDAQ:DRTS) Financial Survey - Defense World
Support Test: Should I invest in Alpha Tau Medical Ltd. before earningsPortfolio Performance Report & Fast Gain Stock Trading Tips - mfd.ru
Alpha Tau Medical (NASDAQ:DRTS) Upgraded at Zacks Research - Defense World
Alpha Tau Medical (NASDAQ:DRTSW) Trading Down 2.2% – Should You Sell? - Defense World
VIX Spike: Is Alpha Tau Medical Ltd Equity Warrant in a bullish channelInsider Buying & Accurate Buy Signal Alerts - baoquankhu1.vn
Is Alpha Tau Medical Ltd. Equity Warrant stock overvalued or fairly priced2025 Market Overview & Safe Capital Preservation Plans - mfd.ru
Is Alpha Tau Medical Ltd. Equity Warrant stock a good pick for beginners2025 Stock Rankings & Real-Time Market Sentiment Reports - mfd.ru
What hedge fund activity signals for Alpha Tau Medical Ltd. stock2025 Short Interest & Accurate Entry and Exit Point Alerts - mfd.ru
Big Picture: What is the Moat Score of Alpha Tau Medical Ltd.Trade Risk Report & Free Risk Controlled Daily Trade Plans - mfd.ru
Can Alpha Tau Medical Ltd. Equity Warrant reach all time highs this yearDip Buying & AI Powered Buy/Sell Recommendations - mfd.ru
Alpha Tau Medical Ltd. (DRTS) Stock Analysis: Unveiling a 10.74% Potential Upside in the Biotech Arena - DirectorsTalk Interviews
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):